The partnership between Royal Philips and Ibex Medical Analytics has expanded to enhance pathology diagnostics through AI technology. In 2021, they integrated Philips IntelliSite Pathology Solution (PIPS) with Ibex’s Galen AI-powered cancer diagnostics platform. This collaboration aims to help pathologists produce objective, reproducible results, boost diagnostic confidence, and improve productivity to meet the rising demand for pathology-based diagnostics. The new alliance focuses on improving diagnostic workflows by offering greater interoperability between their systems. Pathology labs can now use PIPS, which includes a full range of scanners and an image management system, alongside Ibex’s AI tools for diagnosing prostate, breast, and gastric cancers. The companies believe that integrating AI into digital pathology workflows will empower clinicians to generate more reliable results, increase diagnostic confidence, and enhance productivity. This partnership addresses the global shortage of pathologists and the growing number of cancer patients.
Source: www.mobihealthnews.com















